Literature DB >> 11156124

Outcome with high blood lactate levels during cardiopulmonary bypass in adult cardiac operation.

P Demers1, S Elkouri, R Martineau, A Couturier, R Cartier.   

Abstract

BACKGROUND: High blood lactate levels during cardiopulmonary bypass (CPB) are associated with tissue hypoperfusion and may contribute to postoperative complications or death. The objective of this study was to determine an association between blood lactate levels during CPB and perioperative morbidity and mortality.
METHODS: We reviewed 1,376 patients who underwent cardiac operation with CPB. Patients with abnormal preoperative blood lactate levels were excluded (n = 101). Blood lactate concentration during CPB, clinical data, and perioperative events were recorded.
RESULTS: Peak blood lactate levels of 4.0 mmol/L or higher during CPB were present in 227 patients (18.0%). Postoperative mortality was higher in this group than in the patients who had peak blood lactate levels of less than 4.0 mmol/L during CPB (11.0% versus 1.4%; p < 0.001, relative risk [RR] = 9.0). Postoperative hemodynamic instability occurred in 29.5% of patients with elevated levels of lactate during CPB compared with 10.9% of patients with lower lactate levels (p < 0.001, RR = 3.4). Overall, major postoperative complications occurred in 43.2% and 21.8% of patients in each group, respectively (p < 0.001, RR = 2.7). Logistic regression analysis revealed that peak blood lactate levels of 4.0 mmol/L or higher during CPB were strongly associated with postoperative mortality (p = 0.0001) and morbidity (p = 0.013).
CONCLUSIONS: Blood lactate concentration of 4.0 mmol/L or higher during CPB identifies a subgroup of patients with increased risk of postoperative morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11156124     DOI: 10.1016/s0003-4975(00)02160-3

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  38 in total

1.  Is it Time for Goal-Directed Therapy in Perfusion.

Authors:  Robert C Groom
Journal:  J Extra Corpor Technol       Date:  2017-06

Review 2.  Haemodynamic goal-directed therapy in cardiac and vascular surgery. A systematic review and meta-analysis.

Authors:  Mariateresa Giglio; Lidia Dalfino; Filomena Puntillo; Giovanni Rubino; Massimo Marucci; Nicola Brienza
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-07-24

3.  A meta-analysis of renal benefits to pulsatile perfusion in cardiac surgery.

Authors:  Alicia Sievert; Joseph Sistino
Journal:  J Extra Corpor Technol       Date:  2012-03

Review 4.  Subcellular Energetics and Metabolism: Potential Therapeutic Applications.

Authors:  Robert H Thiele
Journal:  Anesth Analg       Date:  2017-06       Impact factor: 5.108

Review 5.  Hyperlactatemia and Cardiac Surgery.

Authors:  Jonathon Minton; David A Sidebotham
Journal:  J Extra Corpor Technol       Date:  2017-03

6.  A bootstrap approach for assessing the uncertainty of outcome probabilities when using a scoring system.

Authors:  Gabriele Cevenini; Paolo Barbini
Journal:  BMC Med Inform Decis Mak       Date:  2010-08-26       Impact factor: 2.796

7.  Intensive care unit admission parameters improve the accuracy of operative mortality predictive models in cardiac surgery.

Authors:  Marco Ranucci; Andrea Ballotta; Serenella Castelvecchio; Ekaterina Baryshnikova; Simonetta Brozzi; Alessandra Boncilli
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

8.  Central venous oxygen saturation and blood lactate levels during cardiopulmonary bypass are associated with outcome after pediatric cardiac surgery.

Authors:  Marco Ranucci; Giuseppe Isgrò; Concetta Carlucci; Teresa De La Torre; Stefania Enginoli; Alessandro Frigiola
Journal:  Crit Care       Date:  2010-08-04       Impact factor: 9.097

Review 9.  What is optimal flow and how to validate this.

Authors:  Filip De Somer
Journal:  J Extra Corpor Technol       Date:  2007-12

10.  [Neuromonitoring and neuroprotection in cardiac anaesthesia. Nationwide survey conducted by the Cardiac Anaesthesia Working Group of the German Society of Anaesthesiology and Intensive Care Medicine].

Authors:  G Erdös; I Tzanova; U Schirmer; J Ender
Journal:  Anaesthesist       Date:  2009-03       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.